Deficiency of myeloid PHD proteins aggravates atherogenesis via macrophage apoptosis and paracrine fibrotic signalling

Abstract Aims Atherosclerotic plaque hypoxia is detrimental for macrophage function. Prolyl hydroxylases (PHDs) initiate cellular hypoxic responses, possibly influencing macrophage function in plaque hypoxia. Thus, we aimed to elucidate the role of myeloid PHDs in atherosclerosis. Methods and results Myeloid-specific PHD knockout (PHDko) mice were obtained via bone marrow transplantation (PHD1ko, PHD3ko) or conditional knockdown through lysozyme M-driven Cre recombinase (PHD2cko). Mice were fed high cholesterol diet for 6–12 weeks to induce atherosclerosis. Aortic root plaque size was significantly augmented 2.6-fold in PHD2cko, and 1.4-fold in PHD3ko compared to controls but was unchanged in PHD1ko mice. Macrophage apoptosis was promoted in PHD2cko and PHD3ko mice in vitro and in vivo, via the hypoxia-inducible factor (HIF) 1α/BNIP3 axis. Bulk and single-cell RNA data of PHD2cko bone marrow-derived macrophages (BMDMs) and plaque macrophages, respectively, showed enhanced HIF1α/BNIP3 signalling, which was validated in vitro by siRNA silencing. Human plaque BNIP3 mRNA was positively associated with plaque necrotic core size, suggesting similar pro-apoptotic effects in human. Furthermore, PHD2cko plaques displayed enhanced fibrosis, while macrophage collagen breakdown by matrix metalloproteinases, collagen production, and proliferation were unaltered. Instead, PHD2cko BMDMs enhanced fibroblast collagen secretion in a paracrine manner. In silico analysis of macrophage-fibroblast communication predicted SPP1 (osteopontin) signalling as regulator, which was corroborated by enhanced plaque SPP1 protein in vivo. Increased SPP1 mRNA expression upon PHD2cko was preferentially observed in foamy plaque macrophages expressing ‘triggering receptor expressed on myeloid cells-2’ (TREM2hi) evidenced by single-cell RNA, but not in neutrophils. This confirmed enhanced fibrotic signalling by PHD2cko macrophages to fibroblasts, in vitro as well as in vivo. Conclusion Myeloid PHD2cko and PHD3ko enhanced atherosclerotic plaque growth and macrophage apoptosis, while PHD2cko macrophages further activated collagen secretion by fibroblasts in vitro, likely via paracrine SPP1 signalling through TREM2hi macrophages.

[1]  C. Glass,et al.  Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics , 2020, Circulation research.

[2]  M. Cybulsky,et al.  Meta-Analysis of Leukocyte Diversity in Atherosclerotic Mouse Aortas , 2020, Circulation research.

[3]  R. Cao,et al.  SPP1 promotes Schwann cell proliferation and survival through PKCα by binding with CD44 and αvβ3 after peripheral nerve injury , 2020, Cell & Bioscience.

[4]  Christian H. Holland,et al.  Transfer of regulatory knowledge from human to mouse for functional genomic analysis. , 2020, Biochimica et biophysica acta. Gene regulatory mechanisms.

[5]  Christian H. Holland,et al.  Robustness and applicability of transcription factor and pathway analysis tools on single-cell RNA-seq data , 2020, Genome Biology.

[6]  Y. Saeys,et al.  NicheNet: modeling intercellular communication by linking ligands to target genes , 2019, Nature Methods.

[7]  V. Fuster,et al.  Transition of Macrophages to Fibroblast-Like Cells in Healing Myocardial Infarction. , 2019, Journal of the American College of Cardiology.

[8]  Hyun-Cheol Lee,et al.  Intracellular sensing of viral genomes and viral evasion , 2019, Experimental & Molecular Medicine.

[9]  C. Ponting,et al.  Resolving the fibrotic niche of human liver cirrhosis at single cell level , 2019, Nature.

[10]  E. McNally,et al.  Spp1 (osteopontin) promotes TGFβ processing in fibroblasts of dystrophin deficient muscles through matrix metalloproteinases. , 2019, Human molecular genetics.

[11]  L. Szczech,et al.  Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis. , 2019, The New England journal of medicine.

[12]  L. Szczech,et al.  Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis. , 2019, The New England journal of medicine.

[13]  Clint L. Miller,et al.  Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis , 2019, Nature Medicine.

[14]  Z. Lok,et al.  Osteopontin in Vascular Disease: Friend or Foe? , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[15]  Christoph Hafemeister,et al.  Comprehensive integration of single cell data , 2018, bioRxiv.

[16]  Laura S. Shankman,et al.  Irradiation abolishes smooth muscle investment into vascular lesions in specific vascular beds. , 2018, JCI insight.

[17]  G. Bergström,et al.  Novel Multiomics Profiling of Human Carotid Atherosclerotic Plaques and Plasma Reveals Biliverdin Reductase B as a Marker of Intraplaque Hemorrhage , 2018, JACC. Basic to translational science.

[18]  J. Sáez-Rodríguez,et al.  Benchmark and integration of resources for the estimation of human transcription factor activities , 2018, bioRxiv.

[19]  Dennis Wolf,et al.  Single-Cell RNA-Seq Reveals the Transcriptional Landscape and Heterogeneity of Aortic Macrophages in Murine Atherosclerosis , 2018, Circulation research.

[20]  T. Iida,et al.  Is Osteopontin a Friend or Foe of Cell Apoptosis in Inflammatory Gastrointestinal and Liver Diseases? , 2017, International journal of molecular sciences.

[21]  D. Katschinski,et al.  Loss of PHD3 in myeloid cells dampens the inflammatory response and fibrosis after hind-limb ischemia , 2017, Cell Death & Disease.

[22]  E. Warburton,et al.  Vascular Imaging With 18F-Fluorodeoxyglucose Positron Emission Tomography Is Influenced by Hypoxia , 2017, Journal of the American College of Cardiology.

[23]  Hiroshi Iwata,et al.  Adventitial MSC-like Cells Are Progenitors of Vascular Smooth Muscle Cells and Drive Vascular Calcification in Chronic Kidney Disease. , 2016, Cell stem cell.

[24]  A. Shah,et al.  PHD2 Is a Regulator for Glycolytic Reprogramming in Macrophages , 2016, Molecular and Cellular Biology.

[25]  P. Carmeliet,et al.  Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia. , 2016, European heart journal.

[26]  M. Colonna,et al.  MHC II+ resident peritoneal and pleural macrophages rely on IRF4 for development from circulating monocytes , 2016, The Journal of experimental medicine.

[27]  C. H. Nielsen,et al.  Hypoxia-Inducible Factor-1&agr; Expression in Macrophages Promotes Development of Atherosclerosis , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[28]  V. Fuster,et al.  Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability , 2016, Nature Communications.

[29]  James E. Novak,et al.  Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[30]  Lior Pachter,et al.  Near-optimal probabilistic RNA-seq quantification , 2016, Nature Biotechnology.

[31]  R. Serpi,et al.  Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[32]  A. Rastogi,et al.  Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia. , 2016, Journal of the American Society of Nephrology : JASN.

[33]  A. Gabrielsen,et al.  Gene expression signatures, pathways and networks in carotid atherosclerosis , 2016, Journal of internal medicine.

[34]  Jaroslav Pelisek,et al.  Deficiency of HIF1&agr; in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[35]  S. Carr,et al.  The extracellular matrix: Tools and insights for the "omics" era. , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[36]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[37]  Maarten Merkx,et al.  Colorful Protein-Based Fluorescent Probes for Collagen Imaging , 2014, PloS one.

[38]  P. Lambin,et al.  Reversal of Hypoxia in Murine Atherosclerosis Prevents Necrotic Core Expansion by Enhancing Efferocytosis , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[39]  T. Wolak.  Osteopontin - a multi-modal marker and mediator in atherosclerotic vascular disease. , 2014, Atherosclerosis.

[40]  C. Fan,et al.  Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase , 2014, Genes & development.

[41]  K. Alitalo,et al.  Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis , 2011, Nature.

[42]  R. Mecham,et al.  Vascular Calcification and Aortic Fibrosis: A Bifunctional Role for Osteopontin in Diabetic Arteriosclerosis , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[43]  Helga Thorvaldsdóttir,et al.  Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..

[44]  S. Frede,et al.  Acute Hypoxia Induces HIF-Independent Monocyte Adhesion to Endothelial Cells through Increased Intercellular Adhesion Molecule-1 Expression: The Role of Hypoxic Inhibition of Prolyl Hydroxylase Activity for the Induction of NF-κB , 2010, The Journal of Immunology.

[45]  G. Keren,et al.  HIF-1&agr; Overexpression and Experimental Murine Atherosclerosis , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[46]  Teresa Pereira,et al.  Stabilization of HIF-1α is critical to improve wound healing in diabetic mice , 2008, Proceedings of the National Academy of Sciences.

[47]  W. Kaelin,et al.  Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. , 2008, Molecular cell.

[48]  Mathijs Groeneweg,et al.  Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. , 2008, Journal of the American College of Cardiology.

[49]  P. Carmeliet,et al.  Abnormal Sympathoadrenal Development and Systemic Hypotension in PHD3−/− Mice , 2008, Molecular and Cellular Biology.

[50]  Robert A. Harris,et al.  Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism , 2008, Nature Genetics.

[51]  K. Takeda,et al.  Essential Role for Prolyl Hydroxylase Domain Protein 2 in Oxygen Homeostasis of the Adult Vascular System , 2007, Circulation.

[52]  Mengsu Yang,et al.  Effect of hypoxia on RAW264.7 macrophages apoptosis and signaling. , 2007, Toxicology.

[53]  Y. Kitaura,et al.  Chronic Hypoxia Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Knockout Mice , 2005, Hypertension Research.

[54]  C. Print,et al.  Hypoxia-induced neutrophil survival is mediated by HIF-1α–dependent NF-κB activity , 2005, The Journal of experimental medicine.

[55]  D. Heinegård,et al.  Altered Vascular Remodeling in Osteopontin-Deficient Atherosclerotic Mice , 2004, Journal of Vascular Research.

[56]  W. Reith,et al.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice , 1999, Transgenic Research.

[57]  C. E. West,et al.  Separation of plasma lipoproteins by density-gradient ultracentrifugation. , 1975, Analytical biochemistry.

[58]  M. Simon,et al.  Hypoxia-inducible factors as essential regulators of inflammation. , 2010, Current topics in microbiology and immunology.